Skip to main content
. Author manuscript; available in PMC: 2018 Oct 1.
Published in final edited form as: Shock. 2017 Oct;48(4):490–497. doi: 10.1097/SHK.0000000000000886

Figure 5. Iron status and utilization in inflamed WT and HKO mice undergoing delayed treatment with Fe and/or EPO.

Figure 5

(A) Liver iron. (B) Serum iron. (C) Δ MCV. (D) Spleen weights. The dashed lines represent the mean values from the uninflamed control WT mice of Figure 1. Treatment groups for each genotype included 7–10 evaluable male mice. Medians ± 75th/25th percentile are shown; *p<0.05 and **p<0.001 compared to saline group, †p<0.05 and ††p<0.001 compared to genotype counterpart, all by Holm-Sidak method.